8860 Lendelede, de
+32 (51) 3203-72
The Aspects of Pharmaceutical Pricing
State-of-the-art pricing knowledge
A current analysis of McKinsey shows that over the years, real price increases - rewarding past innovation and changes in ways for treating patients - have been the main driver of the pharmaceutical industry's development. Less attention has been paid to managing the cost base. Lowering the profit margins will suggest a need for new business models.
If you want to learn more about the aspects of pharmaceutical pricing, you can attend this interactive course, organized by the European Pricing Platform. This course addresses the critical policy issues in developing the best pricing strategy for your pharmaceutical products. Attend this unique opportunity to hear best practices from Raf De Wilde, a Healthcare Pricing and Market Access Expert.
Venue: Husa President Park Hotel, Brussels (Belgium)
Date: 13th and 14th of March 2012
Trainer: Raf De Wilde - Associate Vice President - United BioSource Corporation
Do you want more information about this practical and interactive training? Please visit, http://www.pricingplatform.eu/site/public/trainings_detail.asp?id=131
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.